ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity)

 

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) is a fundamental bottleneck in drug discovery, accounting for nearly half of all late-stage clinical failures. AI transforms this process by predicting how a compound behaves in the human body computationally, saving millions of dollars and years of development time.

Why ADMET is the Core of AI Drug Discovery High Attrition Prevention: AI models screen massive chemical libraries to flag dangerous, poorly absorbed, or toxic molecules long before costly wet-lab experiments. Accelerated Lead Optimization: Deep learning and graph neural networks help iteratively modify chemical structures to improve safety and efficacy. Multi-Endpoint Evaluation: Modern algorithms don't just test a single trait; they evaluate multi-organ toxicities and drug-likeness simultaneously. Key AI Approaches Used Graph Neural Networks (GNNs): Map the 2D structures and atoms of molecules to highly accurate property predictions. Generative Models: AI can invent entirely new, optimized drug-like molecules that naturally satisfy strict ADMET thresholds. Large Language Models (LLMs): Increasingly fine-tuned on compound and bioassay data to enhance benchmark scoring and chemical reasoning. How AI Identifies Drug Toxicity In Silico Predictive Modeling: AI uses algorithms like Graph Neural Networks (GNNs) and Quantitative Structure-Activity Relationship (QSAR) to analyze molecular structures. By converting chemical structures into mathematical data, the model can map structural features to known toxic outcomes. Deep Learning & Multitask Frameworks: Platforms can predict multiple toxicity endpoints simultaneously. For example, they can scan for hepatotoxicity (liver damage), cardiotoxicity (such as hERG channel inhibition), and mutagenicity all at once. Target and Off-target Binding: AI assesses whether a drug molecule will unintentionally interact with unintended proteins or receptors (off-target effects), which is a primary driver of adverse drug reactions. AI models are only as good as the data they are trained on. To identify toxicity, models are fed high-quality data from: Biological Experimental Data: Includes in vitro cytotoxicity tests (measuring cell viability and apoptosis) and historical animal trial data. Toxicological Databases: Massive databases like PubChem, ChEMBL, and Tox21 are utilized to train AI algorithms to recognize chemical patterns associated with toxicity. Common AI ADMET Platforms ADMETlab 3.0: A comprehensive, multi-endpoint platform designed to evaluate and profile drug candidates. pkCSM: A graph-based signature method that predicts pharmacokinetic and toxicity properties. SwissADME: A widely used web tool that evaluates pharmacokinetics, drug-likeness, and medicinal chemistry friendliness.